Premium
A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma
Author(s) -
Lee Hans C.,
Feng Lei,
Oriabure Onyeka,
Graham Vivian,
Chen Wendy,
Badillo Maria,
Lu Rebecca,
Lee Hun J.,
Jain Preetesh,
Manasanch Elisabet E.,
Orlowski Robert Z.,
Wang Michael L.
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26178
Subject(s) - bendamustine , carfilzomib , medicine , multiple myeloma , nitrogen mustard , proteasome inhibitor , oncology , melphalan , pharmacology , salvage therapy , cancer research , tolerability , cyclophosphamide , chemotherapy , leukemia , chronic lymphocytic leukemia , adverse effect
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom